Novel Strategies for Thyroid Disorders: Beyond Hormones

Thyroid disorders are a prevalent and diverse group of conditions that affect millions of people worldwide. The conventional treatment approach has predominantly relied on hormone replacement therapy for hypothyroidism and antithyroid medications for hyperthyroidism. However, this chapter moves into the dynamic landscape of thyroid disorder management by spotlighting innovative pharmacotherapies and diagnostic advancements that extend beyond traditional paradigms. The chapter begins by elucidating the thyroid’s intricate physiology and pathophysiology, providing the foundation for understanding the discussed therapies. It scrutinizes the traditional approaches and then pivots to unveil the exciting array of emerging pharmacotherapies, including TSH receptor agonists for hypothyroidism, targeted therapies for thyroid cancer, and novel interventions for hyperthyroidism and goiter. Moreover, this chapter explores diagnostic tools and biomarkers, shedding light on how precision medicine is revolutionizing the diagnosis and management of thyroid disorders. The narrative emphasizes the need 32 for patient-centered care, shared decision-making, and consideration of potential side effects and safety concerns associated with these promising treatments. Ultimately, “Emerging Therapies for Thyroid Disorders” offers a comprehensive overview of the latest developments in thyroid disorder management. This knowledge equips healthcare professionals, researchers, and students with the tools and insights to optimize patient care, enhance research endeavors, and propel the field of endocrine and metabolic diseases toward a brighter and more personalized future.